BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28252221)

  • 1. Bone Marrow-Derived Mesenchymal Stem Cells-Mediated Protection Against Organ Dysfunction in Disseminated Intravascular Coagulation Is Associated With Peripheral Immune Responses.
    Wang B; Wu S; Wang T; Ma Z; Liu K
    J Cell Biochem; 2017 Oct; 118(10):3184-3192. PubMed ID: 28252221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC model.
    Wang B; Wu S; Ma Z; Wang T; Yang C
    Cell Death Dis; 2018 Oct; 9(10):1024. PubMed ID: 30282969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model.
    Wang B; Wu SM; Wang T; Liu K; Zhang G; Zhang XQ; Yu JH; Liu CZ; Fang CC
    Chin Med J (Engl); 2012 May; 125(10):1753-9. PubMed ID: 22800895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
    Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation].
    Qi BD; Meng BX; Yang Y; Liu B; Li CC; Xia W; Guo SZ; Zhang C
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):207-12. PubMed ID: 21838003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of HMGB1-RAGE/TLRs-NF-κB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats].
    Xiu G; Xiong W; Yin Y; Chen X; Liu P; Sun J; Ling B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):830-835. PubMed ID: 30309407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
    Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels.
    Asakura H; Asamura R; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Yoshida T; Miyamoto K; Nakao S
    Thromb Haemost; 2005 Apr; 93(4):724-8. PubMed ID: 15841319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Mesenchymal Stem Cells Suppress Acute Lung Injury Induced by Lipopolysaccharide Through Inhibiting the TLR2, 4/NF-κB Pathway in Rats with Multiple Trauma.
    Li D; Pan X; Zhao J; Chi C; Wu G; Wang Y; Liao S; Wang C; Ma J; Pan J
    Shock; 2016 Jun; 45(6):641-6. PubMed ID: 26717106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
    Asakura H; Sano Y; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
    Intensive Care Med; 2004 Oct; 30(10):1950-5. PubMed ID: 15480547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy.
    Liao L; Shi B; Chang H; Su X; Zhang L; Bi C; Shuai Y; Du X; Deng Z; Jin Y
    Theranostics; 2017; 7(1):106-116. PubMed ID: 28042320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of bone marrow mesenchymal stem cells with CTLA4Ig and CD40LIg gene modification in rejection reaction after liver transplantation].
    Sun C; Zhang J; Yin DL; Li K; Wang Q; Xie YH; Li W
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):54-59. PubMed ID: 29804363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of human hepatocyte growth factor gene-modified bone marrow mesenchymal stem cells on immunological rejection after allograft liver transplantation in rats].
    Zhu J; Chen Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jul; 25(7):871-6. PubMed ID: 21818958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
    Asakura H; Ichino T; Yoshida T; Suga Y; Ontachi Y; Mizutani T; Kato M; Ito T; Yamazaki M; Aoshima K; Morishita E; Saito M; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):233-9. PubMed ID: 11943937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC).
    Wu LC; Lin X; Sun H
    Acta Pharmacol Sin; 2012 Oct; 33(10):1254-9. PubMed ID: 22983394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models.
    Asakura H; Aoshima K; Ichino T; Suga Y; Saito M; Morishita E; Yamazaki M; Ontachi Y; Mizutani T; Kato M; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):301-6. PubMed ID: 11460014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Sano Y; Omote M; Yoshida T; Ontachi Y; Mizutani T; Kaneda M; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
    Int J Hematol; 2004 May; 79(4):394-9. PubMed ID: 15218973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reproduction of a rat model of disseminated intravascular coagulation accompanied by multiple organ injuries].
    Qiao YJ; Zhu JM; Zhang Y; Yuan HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):41-3. PubMed ID: 17207364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation.
    Zhang QY; Guo J; Xu L; Wei Y; Zhou ST; Lu QY; Guo L; Sun QY
    BMC Complement Med Ther; 2022 Sep; 22(1):245. PubMed ID: 36127691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of exogenous bone marrow‑derived mesenchymal stem cell transplantation on silicosis via paracrine mechanisms in rats.
    Zhao MM; Cui JZ; Cui Y; Li R; Tian YX; Song SX; Zhang J; Gao JL
    Mol Med Rep; 2013 Sep; 8(3):741-6. PubMed ID: 23842733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.